Skip to main content
COCH
NASDAQ Life Sciences

Envoy Medical Beats Q3 Loss Estimates at $0.50/Share, Revenue Up 57%

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.045
Mkt Cap
$54.524M
52W Low
$3.625
52W High
$9.539
52W Position info
94% above low
Off High info
26% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

COCH sits 94% above its 52-week low of $3.625.

Summary

Envoy Medical posted a Q3 adjusted loss of $0.50 per share, well better than the $0.67 consensus and a big improvement from the $3.40 loss a year ago. Revenue rose 57.1% to $66 thousand, though that fell short of the $86.67 thousand analysts expected. The net loss was $5.24 million, and the company ended the quarter with $14.6 million in cash — the same figures disclosed in this morning's 8-K. The cash balance is the number that matters: the last 10-Q flagged runway only through Q1 2027 with going-concern doubt, and this quarter's burn keeps that clock running. The 1-for-10 reverse split took effect October 26, so all per-share figures here are post-split. The stock closed at $7.12, and the median analyst target of $20.00 implies the Street is still pricing the PMA approval path rather than near-term financials.

At the time of this announcement, COCH was trading at $7.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $54.5M. The 52-week trading range was $3.63 to $9.54. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

COCH - Latest Insights

COCH
Nov 05, 2026, 7:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.12
Real-time Price: $7.11 info
Change: -$0.0100 (-0.14%) info
Market Cap: $54.95M info
COCH
Aug 31, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.720
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info
COCH
Aug 19, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.740
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info
COCH
Aug 10, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.705
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info
COCH
Aug 10, 2026, 8:31 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.6932
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info